BetterLife Pharma Inc. (OTCMKTS:BETRF) Short Interest Down 61.0% in July

BetterLife Pharma Inc. (OTCMKTS:BETRF) was the target of a significant decrease in short interest in the month of July. As of July 31st, there was short interest totalling 5,700 shares, a decrease of 61.0% from the July 15th total of 14,600 shares. Based on an average daily volume of 53,600 shares, the days-to-cover ratio is presently 0.1 days.

BetterLife Pharma Stock Down 3.1 %

Shares of OTCMKTS BETRF traded down $0.00 during trading on Thursday, reaching $0.09. 700 shares of the company traded hands, compared to its average volume of 30,913. The firm has a 50 day simple moving average of $0.10 and a 200-day simple moving average of $0.08. The stock has a market capitalization of $11.49 million, a PE ratio of -3.13 and a beta of 1.24. BetterLife Pharma has a 52-week low of $0.03 and a 52-week high of $0.15.

BetterLife Pharma (OTCMKTS:BETRF) last posted its quarterly earnings results on Thursday, June 27th. The company reported ($0.01) EPS for the quarter.

About BetterLife Pharma

BetterLife Pharma Inc, a biotechnology company, engages in the development and commercialization of compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections.